<DOC>
	<DOCNO>NCT00923156</DOCNO>
	<brief_summary>In addition blood pressure lower effect aliskiren , may beneficial effect block call RAAS ( renin-angiotensin-aldosterone system ) tissue level . An increase angiotensin II associate progression heart failure . Although use ACE-inhibitors heart failure show clinical benefit , increase angiotensin II due angiotensin II `` escape '' phenomenon desirable . It yet know direct renin inhibitor reduce even prevent angiotensin II escape phenomenon associate use ACE-inhibitor . Therefore study test effect ramipril , aliskiren combination level angiotensin II blood patient systolic heart failure</brief_summary>
	<brief_title>Effects Aliskiren , Ramipril , Combination Levels Angiotensin II Patients With Decompensated Systolic Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Heart Failure , Systolic</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Angiotensinogen</mesh_term>
	<mesh_term>Angiotensin II</mesh_term>
	<criteria>Decompensated systolic heart failure , leave ventricular ejection fraction ≤40 % Brain natriuretic peptide ( BNP ) level ≥ 100 pg/mL Exclusion criterion : Use Angiotensin Converting Enzyme ( ACE ) Angiotensin Receptor Blocker ( ARB ) inhibitor treatment follow runin period requirement treatment Acute heart failure secondary acute myocardial infarction , acute coronary syndrome new tachyarrhythmia Occurrence unstable angina myocardial infarction within 12 week prior screen History cardiomyopathy postpartum , restrictive , infective , hypertrophic obstructive History right heart failure due pulmonary disease History untreated second third degree atrioventricular heart block Other protocoldefined inclusion/exclusion criterion apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>Systolic</keyword>
	<keyword>Aliskiren</keyword>
	<keyword>Ramipril</keyword>
	<keyword>Angiotensin II</keyword>
	<keyword>Ang II</keyword>
	<keyword>Plasma Renin Activity</keyword>
	<keyword>PRA</keyword>
	<keyword>Plasma Renin Concentration</keyword>
	<keyword>PR ,</keyword>
	<keyword>brain natriuretic peptide</keyword>
	<keyword>BNP</keyword>
	<keyword>urinary aldosterone</keyword>
	<keyword>Escape</keyword>
	<keyword>Pharmacokinetic</keyword>
	<keyword>PK</keyword>
</DOC>